Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up
Adult
Original Communication
SARS-CoV-2
Clinical Neurology
COVID-19
3. Good health
Stroke
03 medical and health sciences
0302 clinical medicine
Neurology
Peripheral Nervous System
Humans
RNA, Viral
Prospective Studies
Follow-Up Studies
DOI:
10.1007/s00415-020-10380-x
Publication Date:
2021-01-13T23:36:37Z
AUTHORS (21)
ABSTRACT
To systematically describe central (CNS) and peripheral (PNS) nervous system complications in hospitalized COVID-19 patients.We conducted a prospective, consecutive, observational study of adult patients from tertiary referral center with confirmed COVID-19. All were screened daily for neurological neuropsychiatric symptoms during admission discharge. Three-month follow-up data collected using electronic health records. We classified as caused by SARS-CoV-2 neurotropism, immune-mediated or critical illness-related.From April to September 2020, we enrolled 61 consecutively admitted patients, 35 (57%) whom required intensive care (ICU) management respiratory failure. Forty-one CNS/PNS identified 28 (45.9%) more frequent ICU compared non-ICU patients. The most common CNS complication was encephalopathy (n = 19, 31.1%), which severe 13 (GCS ≤ 12), including 8 akinetic mutism. Length independently associated (OR 1.22). Other included ischemic stroke, biopsy-proven acute necrotizing encephalitis, transverse myelitis. PNS illness polyneuromyopathy (13.1%), prolonged stay independent predictor 1.14). Treatment-related meralgia paresthetica. Of 41 total, 3 para/post-infectious, 34 secondary other causes, 4 remained unresolved. Cerebrospinal fluid negative RNA all 5 investigated.CNS particularly the ICU, often attributable illness. When primary cause disease, no signs viral neurotropism detected, but laboratory changes suggested autoimmune-mediated mechanisms.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (42)
CITATIONS (63)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....